Literature DB >> 17218415

Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.

Yuki Hirono1, Takanobu Yoshimoto, Noriko Suzuki, Toru Sugiyama, Maya Sakurada, Shinji Takai, Naohiko Kobayashi, Masayoshi Shichiri, Yukio Hirata.   

Abstract

Recently, aldosterone has been shown to activate local renin-angiotensin system in vitro. To elucidate the potential role of local renin-angiotensin system in aldosterone-induced cardiovascular injury, we investigated the effects of selective mineralocorticoid receptor (MR) antagonist eplerenone (EPL), angiotensin (Ang) II type 1 receptor antagonist candesartan (ARB), and superoxide dismutase mimetic tempol (TEM) on the development of hypertension, vascular injury, oxidative stress, and inflammatory-related gene expression in aldosterone-treated hypertensive rats. The increased systolic blood pressure and vascular inflammatory changes were attenuated by cotreatment either with EPL, ARB, or TEM. Aldosterone increased angiotensin-converting enzyme expression in the aortic tissue; its effects were blocked by EPL but not by ARB or TEM. Aldosterone also increased Ang II contents in the aortic tissue in the presence of low circulating Ang II concentrations. Aldosterone induced expression of various inflammatory-related genes, whose effects were abolished by EPL, whereas the inhibitory effects of ARB and TEM varied depending on the gene. Aldosterone caused greater accumulation of the oxidant stress marker 4-hydroxy-2-neonenal in the endothelium; its effect was abolished by EPL, ARB, or TEM. Aldosterone increased mRNA levels of reduced nicotinamide adenine dinucleotide phosphate oxidase components; their effect was abolished by EPL, whereas ARB and TEM decreased only the p47phox mRNA level but not that of p22phox or gp91phox. The present findings suggest that the Ang II-dependent pathway resulting from vascular angiotensin-converting enzyme up-regulation and Ang II-independent pathway are both involved in the underlying mechanisms resulting in the development of hypertension, vascular inflammation, and oxidative stress induced by aldosterone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218415     DOI: 10.1210/en.2006-1157

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

1.  Aldosterone stimulates superoxide production in macula densa cells.

Authors:  Xiaolong Zhu; R Davis Manning; Deyin Lu; Celso E Gomez-Sanchez; Yiling Fu; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Inflammatory cell markers as indicators of atherosclerotic renovascular disease.

Authors:  Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

Review 3.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

4.  Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?

Authors:  Yang Yu; Shun-Guang Wei; Zhi-Hua Zhang; Elise Gomez-Sanchez; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2008-01-28       Impact factor: 10.190

Review 5.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

6.  High-sodium intake aggravates myocardial injuries induced by aldosterone via oxidative stress in Sprague-Dawley rats.

Authors:  Jing-yi Li; Shao-ling Zhang; Meng Ren; Yan-ling Wen; Li Yan; Hua Cheng
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

7.  Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage.

Authors:  G Liu; G-S Yin; J-y Tang; D-J Ma; J Ru; X-H Huang
Journal:  J Hum Hypertens       Date:  2014-02-20       Impact factor: 3.012

Review 8.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

Review 9.  Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.

Authors:  Kathleen V Barrett; Amy T McCurley; Iris Z Jaffe
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-12       Impact factor: 2.557

Review 10.  The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.

Authors:  Fabrizio Montecucco; Aldo Pende; François Mach
Journal:  Mediators Inflamm       Date:  2009-04-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.